Skip to Main Content
Qurgen Qurgen
Menu Button

Sep. 19, 2023

Brand Icon
  • Qurgen has achieved a key milestone: the first patient with late stage of rectal adenocarcinoma has received the first dose of SON-DP with no major adverse effects.

Recent news & press

2026
Prof Wang was invited to attend Tigermed's ASCO Pre-Event Webinar as a Speaker to introduce...
Learn More
Apr. 2026
no infusion related reaction (IRR) has occurred during the 48-hour continuous infusion by pump, this...
Learn More